title: PEG-interferon versus conventional interferon and liver fibrosis: do we have evidence of superiority?
authors.forename: Guilherme
authors.initials: G
authors.lastname: Sander
authors.forename: Paulo D
authors.initials: PD
authors.lastname: Picon
authors.forename: Flávio D
authors.initials: FD
authors.lastname: Fuchs
authors.forename: Alberto
authors.initials: A
authors.lastname: Beltrame
authors.forename: Renilson R
authors.initials: RR
authors.lastname: De Souza
mesh_terms: D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D007372:Interferons; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a